Home
HomeAbout Us...Investor RelationsOur DivisionsEssential ScienceNewsroomContact Us
    Business Overview
    Patent Portfolio
    Management
    Board of Directors


Nutrition 21, Inc.
4 Manhattanville Road
Purchase, NY 10577
Phone: 914-701-4500


Patent Portfolio

Nutrition 21’s proven ability to identify, develop and successfully market patented ingredients and products provides a degree of competitive insulation in the marketplace, and is a competency infrequently cultivated in the nutrition industry. Its intellectual property estate is a distinguishing Company hallmark.

The Company honed its patent expertise in its early years as a biotechnology company focused on anti-microbial drug development, and then translated this expertise to the nutrition sector when it began repositioning itself in 1995 as a nutrition company.

In past years, the patent portfolio has contributed to the success and growth of the company in the following ways:

• Issued patents have helped establish and maintain a premium market for the nutritional uses of the Company’s flagship ingredient, Chromax® chromium picolinate in the human nutrition and animal feed markets

• In-licensing and purchase of patents has secured rights to new ingredients and potentially promising new product opportunities

• The competitive advantage secured through newly issued patents on new chromium-based nutrition and other nutritional therapies provides cost justification for the research programs required to bring these new therapies to market

• Cost-effective patent monitoring and enforcement efforts have made a significant positive contribution to bottom-line results

• Out-licensing of nisin and lysostaphin technologies

The Company continues to build on its existing intellectual property estate, and actively manages this asset to create added value for all of the Company’s stakeholders.


© 2004 Nutrition 21 | Privacy Policy | Terms and Conditions